Navigation Links
Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42%
Date:7/18/2014

2.5 (215.5) - 989.7 Numerator for diluted EPS 753.5 231.0 165.7 52.5 2.5 (215.5) - 989.7 Weighted average number of shares (millions) - diluted 590.3 - - - - - - 590.3 Diluted earnings per ADS 382.8c 117.4c 84.4c 26.8c 1.2c (109.5) - 503.1c

The following items are included in Adjustments:

  1. Amortization and asset impairments: Impairment of IPR&D intangible assets ($188.0 million), amortization of intangible assets relating to intellectual property rights acquired ($119.0 million), and tax effect of adjustments;
  2. Acquisitions and integration activities: Unwind of ViroPharma inventory fair value adjustments ($72.5 million), costs primarily associated with acquisition of ViroPharma ($97.3 million), net charge related to the change in fair values of contingent consideration liabilities ($21.4 million), and tax effect of adjustments;
  3. Divestments, reorganizations and discontinued operations: Gain on sale of CALCICHEW product rights and on re-measurement of DAYTRANA contingent consideration to fair value ($40.2 million), costs relating to the One Shire reorganization ($95.2 million), gain on sale of long term investments ($5.0 million), tax effect of adjustments and loss from discontinued operations, net of tax ($27.9 million);
  4. Legal and litigation costs: Costs related to litigation, government investigations, other disputes and external legal costs ($3.9 million), and tax effect of adjustments;
  5. Other: Net income tax credit related to the settlement of certain tax positions with the Canadian revenue authorities ($216.0 million), related interest income received in respect of cash deposited with the Canadian revenue authorities ($18.6 million), costs associated with the  recommended combination of Shire and AbbVie ($19.1 million), and tax effect of adjustment; and
  6. Depreciation reclassification: Depreciation of $81.5 million included in Cost of product
    '/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
2. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
3. Shire Extends Tender Offer for ViroPharma
4. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
5. MinuteClinic Opens First Clinic Locations in New Hampshire
6. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Shire to Present at the Morgan Stanley Global Healthcare Conference
9. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
10. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
11. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 E-QURE, Corp. ... engaged in the development and commercialization of its Bio-electrical ... electrotherapy for the noninvasive treatment of hard to heal ... Zacks Small Cap Research http://scr.zacks.com issued a ... According to Zacks, research update, E-QURE Corp "…has a ...
(Date:5/27/2015)... Medical Device Contract Manufacturing - new study ... Where is the market for medical device ... for this market and medical device outsourcing ... you potential revenues and other trends to 2025, discussing ... report provides 127 tables, charts, and graphs. Discover the ...
(Date:5/27/2015)... 27, 2015  Foundation Health Care  (FDNH), which owns ... services, announced today it will present at the LD ... at Luxe Sunset Boulevard Hotel, Los Angeles, ... June 2 nd at 3:00pm and will also ... meeting please contact LD Micro. For more information about ...
Breaking Medicine Technology:Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 2Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 3Medical Device Contract Manufacturing Market Forecast 2015-2025 2Medical Device Contract Manufacturing Market Forecast 2015-2025 3Medical Device Contract Manufacturing Market Forecast 2015-2025 4Medical Device Contract Manufacturing Market Forecast 2015-2025 5Medical Device Contract Manufacturing Market Forecast 2015-2025 6Medical Device Contract Manufacturing Market Forecast 2015-2025 7
... A new visual evoked potential method has been ... with ocular and/or neurological conditions. The research team of ... at the SUNY State College of Optometry, Department of ... called "Effect of Different Stimulus Configurations on the Visually ...
... YORK, Aug. 2, 2011 Hadasit Bio-Holdings, Ltd. ... biotech companies, all based on intellectual property developed ... medical research center, and its subsidiary, BioMarCare Technologies ... Research and Development (BIRD) Foundation has given initial ...
Cached Medicine Technology:A New, Objective Way to Assess Visual Fields: Visual Evoked Potentials 2A New, Objective Way to Assess Visual Fields: Visual Evoked Potentials 3BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 2BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc. 3
(Date:5/27/2015)... May 27, 2015 With InnerVoice Communication ... environment where the message is not only heard but seen ... or virtually any motivating image. This award-winning and affordable app ... , Now, using InnerVoice Sender app in ... sent to a learner remotely for no additional cost. , ...
(Date:5/27/2015)... SmarterSkin, http://www.smarterskindermatology.com , is taking skin care ... makes it easier for patients to find skin care products ... Sejal Shah is a cosmetic dermatologist based in New York ... test. This revolutionary DNA test uses 16 genetic markers to ... , 1. Firmness and elasticity , 2. Glycation , ...
(Date:5/27/2015)... May 27, 2015 Splashtop Inc., the worldwide ... to its screen mirroring and extended display product line -- ... conference room, classroom, or family room, users can instantly stream ... / display connecting to an Apple TV, a computer, or ... Amazon Fire TV Stick, or the Google Nexus Player. ...
(Date:5/27/2015)... Laguna Hills, CA (PRWEB) May 27, 2015 ... management and workflow solutions, announced today their Premier Sponsorship ... place at the Glendale Hilton on Thursday, May 28th ... dramatically improving business as well as the roadmap to ... technology consulting firm specializing in the sale, installation and ...
(Date:5/27/2015)... 2015 The Society for Women's ... thought leader in research on sex differences in health ... campaign uniting survivors, advocates, organizations, and celebrities in bringing ... disease. The campaign features a short film that ... with chronic disease as a result of their abuse, ...
Breaking Medicine News(10 mins):Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 2Health News:Splashtop Launches the Fastest Computer Screen Mirroring and Extended Display Solution – to Apple TV and other Smart Displays 3Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3
... hospitals to vaccinate all children , MONDAY, March 8 (HealthDay ... with hepatitis B aren,t getting treatments that have been shown ... , Given within 24 hours of birth, the hepatitis B ... 95 percent of newborns from becoming infected, even if they ...
... , ... ... , ... , , ...
... ... ... ... ...
... , ... ... ... ...
... , ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:1 in 5 At-Risk U.S. Babies Doesn't Get Hepatitis B Vaccine 2Health News:1 in 5 At-Risk U.S. Babies Doesn't Get Hepatitis B Vaccine 3Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 2Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 3Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 4Health News:World Cocoa Foundation Launches Cocoa Livelihoods Program in Nigeria 5Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 2Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 3Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 4Health News:Roche/Genentech/Chugai's Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer 5Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 2Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 3Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 4Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 5Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 6Health News:NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome 7Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 2Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 3Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 4Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 5Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 6Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 7Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 8Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 9Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 10Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 11Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 12Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 13Health News:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results 14Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 2Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 3Health News:Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: